Showing results (11-20 of 73) with videos related to

Sort By:
Pageof 8
International Journal of Chronic Obstructive Pulmonary Disease|May 8, 2023
Burden of Disease in Patients with Mild or Mild-to-Moderate Chronic Obstructive Pulmonary Disease (Global Initiative for Chronic Obstructive Lung Disease Group A or B): A Systematic Literature ReviewAlexandrosz Czira, Sneha Purushotham, Ike Iheanacho, et al.
International Journal of Chronic Obstructive Pulmonary Disease|August 28, 2023
Cost-Effectiveness of Single-Inhaler Triple Therapy (FF/UMEC/VI) versus Tiotropium Monotherapy in Patients with Symptomatic Moderate-to-Very Severe COPD in the UKRobyn Kendall, Alan A Martin, Dhvani Shah, et al.
Pulmonary Therapy|February 7, 2020
A Network Meta-Analysis of Long-Acting Muscarinic Antagonist (LAMA) and Long-Acting β2-Agonist (LABA) Combinations in COPDKatya Y J Sion, Eline L Huisman, Yogesh S Punekar, et al.
International Journal of Chronic Obstructive Pulmonary Disease|March 31, 2023
COPD Exacerbations, Costs, and Health Care Resource Utilization Before and After Initiation of Fluticasone Furoate/Umeclidinium/Vilanterol in Routine Care in the USANicola A Hanania, Scott H Bunner, Lindsay G S Bengtson, et al.
International Journal of Chronic Obstructive Pulmonary Disease|September 23, 2021
Healthcare, Medication Utilization and Outcomes of Patients with COPD by GOLD Classification in EnglandLeah B Sansbury, Kieran J Rothnie, Chanchal Bains, et al.
Respiratory Medicine|December 5, 2018
Cost-effectiveness of umeclidinium as add-on to ICS/LABA therapy in COPD: A UK perspectiveMaurice Driessen, Dhvani Shah, Nancy Risebrough, et al.
Cost Effectiveness and Resource Allocation : C/E|May 19, 2018
Cost-effectiveness of umeclidinium compared with tiotropium and glycopyrronium as monotherapy for chronic obstructive pulmonary disease: a UK perspectiveDhvani Shah, Maurice Driessen, Nancy Risebrough, et al.
BMC Neurology|November 7, 2007
Brain type carnosinase in dementia: a pilot studyCynthia M Balion, Carolyn Benson, Parminder S Raina, et al.
Respiratory Research|January 27, 2018
Single-inhaler fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol plus umeclidinium using two inhalers for chronic obstructive pulmonary disease: a randomized non-inferiority studyPeter R Bremner, Ruby Birk, Noushin Brealey, et al.
Respiratory Medicine|September 2, 2014
COST-effectiveness of salmeterol/fluticasone propionate combination (Advair(®)) in uncontrolled asthma in CanadaAfisi S Ismaila, Nancy Risebrough, Chunmei Li, et al.
Pageof 8